Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
ARGX compared with MDGL: revenue, margins and what each company keeps, and the suppliers and customers both name
ARGX
Argenx SE
Change
Mkt cap
Revenue
Revenue
MDGL
Madrigal Pharmaceuticals, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
ARGX
Argenx SE
vs
MDGL
Madrigal Pharmaceuticals, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Supply-chain overlap
Desk
News
Calendar
Saved
Search
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only ARGX
3
ABBV
AbbVie
customer
HALO
Halozyme Therapeutics
supplier
—
AgomAb Therapeutics
unlisted
customer
Shared
0
No shared counterparties.
Only MDGL
8
PFE
Pfizer
supplier
—
Gregory Pharmaceutical Holdings, Inc. (d/b/a UPM Pharmaceuticals)
unlisted
supplier
—
Roche
unlisted
supplier
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
—
Cowen
unlisted
supplier
4 more · MDGL chain
›
ARGX
Argenx SE
Change
881.08
▼
−1.32%
Mkt cap
$55.3B
Revenue
—
Revenue
—
MDGL
Madrigal Pharmaceuticals, Inc.
Change
431.84
▲
+0.34%
Regular session
Sep 2 '83
Mkt cap
$9.9B
Revenue
$364M
Q2 FY26
Revenue
$958M
FY25
vs
Compare
Regular session
Sep 2 '83
ARGX
Argenx SE
vs
MDGL
Madrigal Pharmaceuticals, Inc.
881.08
▼
−1.32%
Price
431.84
▲
+0.34%
$55.3B
Mkt cap
$9.9B
—
Revenue
$364M
Q2 FY26
—
Revenue
$958M
FY25
Change
Change
ARGX
881.08
▼
−1.32%
vs
MDGL
431.84
▲
+0.34%
Regular session
Sep 2 '83